We next validated the impact of the i.c.v. AAV9-mediated delivery of IDSspSGSH-IRES-SUMF1 on behavioral deficits that manifest in 6- and 9-months-old MPS-IIIA mice. This evidence concerns the gene SUMF1 and mucopolysaccharidosis.